Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Identifieur interne : 000950 ( Main/Exploration ); précédent : 000949; suivant : 000951Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Auteurs : Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie]Source :
- International journal of rheumatic diseases [ 1756-185X ] ; 2019.
Descripteurs français
- KwdFr :
- Adolescent, Antirhumatismaux (effets indésirables), Antirhumatismaux (usage thérapeutique), Arthrite juvénile (diagnostic), Arthrite juvénile (immunologie), Arthrite juvénile (mortalité), Arthrite juvénile (traitement médicamenteux), Densité osseuse (), Défaillance multiviscérale (immunologie), Défaillance multiviscérale (mortalité), Enfant, Enfant d'âge préscolaire, Facteurs de risque, Facteurs temps, Femelle, Hormones corticosurrénaliennes (effets indésirables), Hormones corticosurrénaliennes (usage thérapeutique), Humains, Immunosuppresseurs (effets indésirables), Immunosuppresseurs (usage thérapeutique), Induction de rémission, Infections opportunistes (immunologie), Infections opportunistes (mortalité), Jeune adulte, Mâle, Produits biologiques (effets indésirables), Produits biologiques (usage thérapeutique), Résultat thérapeutique, Syndrome d'activation macrophagique (immunologie), Syndrome d'activation macrophagique (mortalité), Troubles de la croissance (), Turquie, Études rétrospectives.
- MESH :
- diagnostic : Arthrite juvénile.
- effets indésirables : Antirhumatismaux, Hormones corticosurrénaliennes, Immunosuppresseurs, Produits biologiques.
- immunologie : Arthrite juvénile, Défaillance multiviscérale, Infections opportunistes, Syndrome d'activation macrophagique.
- mortalité : Arthrite juvénile, Défaillance multiviscérale, Infections opportunistes, Syndrome d'activation macrophagique.
- traitement médicamenteux : Arthrite juvénile.
- usage thérapeutique : Antirhumatismaux, Hormones corticosurrénaliennes, Immunosuppresseurs, Produits biologiques.
- Adolescent, Densité osseuse, Enfant, Enfant d'âge préscolaire, Facteurs de risque, Facteurs temps, Femelle, Humains, Induction de rémission, Jeune adulte, Mâle, Résultat thérapeutique, Troubles de la croissance, Turquie, Études rétrospectives.
- Wicri :
- geographic : Turquie.
English descriptors
- KwdEn :
- Adolescent, Adrenal Cortex Hormones (adverse effects), Adrenal Cortex Hormones (therapeutic use), Antirheumatic Agents (adverse effects), Antirheumatic Agents (therapeutic use), Arthritis, Juvenile (diagnosis), Arthritis, Juvenile (drug therapy), Arthritis, Juvenile (immunology), Arthritis, Juvenile (mortality), Biological Products (adverse effects), Biological Products (therapeutic use), Bone Density (drug effects), Child, Child, Preschool, Female, Growth Disorders (chemically induced), Humans, Immunosuppressive Agents (adverse effects), Immunosuppressive Agents (therapeutic use), Macrophage Activation Syndrome (immunology), Macrophage Activation Syndrome (mortality), Male, Multiple Organ Failure (immunology), Multiple Organ Failure (mortality), Opportunistic Infections (immunology), Opportunistic Infections (mortality), Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Turkey, Young Adult.
- MESH :
- chemical , adverse effects : Adrenal Cortex Hormones, Antirheumatic Agents, Biological Products, Immunosuppressive Agents.
- chemical , therapeutic use : Adrenal Cortex Hormones, Antirheumatic Agents, Biological Products, Immunosuppressive Agents.
- geographic : Turkey.
- chemically induced : Growth Disorders.
- diagnosis : Arthritis, Juvenile.
- drug effects : Bone Density.
- drug therapy : Arthritis, Juvenile.
- immunology : Arthritis, Juvenile, Macrophage Activation Syndrome, Multiple Organ Failure, Opportunistic Infections.
- mortality : Arthritis, Juvenile, Macrophage Activation Syndrome, Multiple Organ Failure, Opportunistic Infections.
- Adolescent, Child, Child, Preschool, Female, Humans, Male, Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Young Adult.
Abstract
Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of JIA characterized by systemic features and poor outcome. We aimed to investigate demographic and clinical features, long-term treatment response and disease complications in a large sJIA cohort.
DOI: 10.1111/1756-185X.13649
PubMed: 31273940
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000347
- to stream PubMed, to step Curation: 000347
- to stream PubMed, to step Checkpoint: 000381
- to stream Ncbi, to step Merge: 002119
- to stream Ncbi, to step Curation: 002119
- to stream Ncbi, to step Checkpoint: 002119
- to stream Main, to step Merge: 000950
- to stream Main, to step Curation: 000950
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.</title>
<author><name sortKey="Barut, Kenan" sort="Barut, Kenan" uniqKey="Barut K" first="Kenan" last="Barut">Kenan Barut</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Adrovic, Amra" sort="Adrovic, Amra" uniqKey="Adrovic A" first="Amra" last="Adrovic">Amra Adrovic</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sahin, Sezgin" sort="Sahin, Sezgin" uniqKey="Sahin S" first="Sezgin" last="Sahin">Sezgin Sahin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tarcin, Gurkan" sort="Tarcin, Gurkan" uniqKey="Tarcin G" first="Gurkan" last="Tarcin">Gurkan Tarcin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tahaoglu, Gulberk" sort="Tahaoglu, Gulberk" uniqKey="Tahaoglu G" first="Gulberk" last="Tahaoglu">Gulberk Tahaoglu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Koker, Oya" sort="Koker, Oya" uniqKey="Koker O" first="Oya" last="Koker">Oya Koker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yildiz, Mehmet" sort="Yildiz, Mehmet" uniqKey="Yildiz M" first="Mehmet" last="Yildiz">Mehmet Yildiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kasapcopur, Ozgur" sort="Kasapcopur, Ozgur" uniqKey="Kasapcopur O" first="Ozgur" last="Kasapcopur">Ozgur Kasapcopur</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31273940</idno>
<idno type="pmid">31273940</idno>
<idno type="doi">10.1111/1756-185X.13649</idno>
<idno type="wicri:Area/PubMed/Corpus">000347</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000347</idno>
<idno type="wicri:Area/PubMed/Curation">000347</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000347</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000381</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000381</idno>
<idno type="wicri:Area/Ncbi/Merge">002119</idno>
<idno type="wicri:Area/Ncbi/Curation">002119</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002119</idno>
<idno type="wicri:Area/Main/Merge">000950</idno>
<idno type="wicri:Area/Main/Curation">000950</idno>
<idno type="wicri:Area/Main/Exploration">000950</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.</title>
<author><name sortKey="Barut, Kenan" sort="Barut, Kenan" uniqKey="Barut K" first="Kenan" last="Barut">Kenan Barut</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Adrovic, Amra" sort="Adrovic, Amra" uniqKey="Adrovic A" first="Amra" last="Adrovic">Amra Adrovic</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sahin, Sezgin" sort="Sahin, Sezgin" uniqKey="Sahin S" first="Sezgin" last="Sahin">Sezgin Sahin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tarcin, Gurkan" sort="Tarcin, Gurkan" uniqKey="Tarcin G" first="Gurkan" last="Tarcin">Gurkan Tarcin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tahaoglu, Gulberk" sort="Tahaoglu, Gulberk" uniqKey="Tahaoglu G" first="Gulberk" last="Tahaoglu">Gulberk Tahaoglu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Koker, Oya" sort="Koker, Oya" uniqKey="Koker O" first="Oya" last="Koker">Oya Koker</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yildiz, Mehmet" sort="Yildiz, Mehmet" uniqKey="Yildiz M" first="Mehmet" last="Yildiz">Mehmet Yildiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kasapcopur, Ozgur" sort="Kasapcopur, Ozgur" uniqKey="Kasapcopur O" first="Ozgur" last="Kasapcopur">Ozgur Kasapcopur</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of rheumatic diseases</title>
<idno type="eISSN">1756-185X</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adrenal Cortex Hormones (adverse effects)</term>
<term>Adrenal Cortex Hormones (therapeutic use)</term>
<term>Antirheumatic Agents (adverse effects)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis, Juvenile (diagnosis)</term>
<term>Arthritis, Juvenile (drug therapy)</term>
<term>Arthritis, Juvenile (immunology)</term>
<term>Arthritis, Juvenile (mortality)</term>
<term>Biological Products (adverse effects)</term>
<term>Biological Products (therapeutic use)</term>
<term>Bone Density (drug effects)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Growth Disorders (chemically induced)</term>
<term>Humans</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Macrophage Activation Syndrome (immunology)</term>
<term>Macrophage Activation Syndrome (mortality)</term>
<term>Male</term>
<term>Multiple Organ Failure (immunology)</term>
<term>Multiple Organ Failure (mortality)</term>
<term>Opportunistic Infections (immunology)</term>
<term>Opportunistic Infections (mortality)</term>
<term>Remission Induction</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Turkey</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Antirhumatismaux (effets indésirables)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Arthrite juvénile (diagnostic)</term>
<term>Arthrite juvénile (immunologie)</term>
<term>Arthrite juvénile (mortalité)</term>
<term>Arthrite juvénile (traitement médicamenteux)</term>
<term>Densité osseuse ()</term>
<term>Défaillance multiviscérale (immunologie)</term>
<term>Défaillance multiviscérale (mortalité)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Hormones corticosurrénaliennes (effets indésirables)</term>
<term>Hormones corticosurrénaliennes (usage thérapeutique)</term>
<term>Humains</term>
<term>Immunosuppresseurs (effets indésirables)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Induction de rémission</term>
<term>Infections opportunistes (immunologie)</term>
<term>Infections opportunistes (mortalité)</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Produits biologiques (effets indésirables)</term>
<term>Produits biologiques (usage thérapeutique)</term>
<term>Résultat thérapeutique</term>
<term>Syndrome d'activation macrophagique (immunologie)</term>
<term>Syndrome d'activation macrophagique (mortalité)</term>
<term>Troubles de la croissance ()</term>
<term>Turquie</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Antirheumatic Agents</term>
<term>Biological Products</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Antirheumatic Agents</term>
<term>Biological Products</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Turkey</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Growth Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Arthritis, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Arthrite juvénile</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Bone Density</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antirhumatismaux</term>
<term>Hormones corticosurrénaliennes</term>
<term>Immunosuppresseurs</term>
<term>Produits biologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Arthrite juvénile</term>
<term>Défaillance multiviscérale</term>
<term>Infections opportunistes</term>
<term>Syndrome d'activation macrophagique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Arthritis, Juvenile</term>
<term>Macrophage Activation Syndrome</term>
<term>Multiple Organ Failure</term>
<term>Opportunistic Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Arthritis, Juvenile</term>
<term>Macrophage Activation Syndrome</term>
<term>Multiple Organ Failure</term>
<term>Opportunistic Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Arthrite juvénile</term>
<term>Défaillance multiviscérale</term>
<term>Infections opportunistes</term>
<term>Syndrome d'activation macrophagique</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Arthrite juvénile</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term>
<term>Hormones corticosurrénaliennes</term>
<term>Immunosuppresseurs</term>
<term>Produits biologiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Remission Induction</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Densité osseuse</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Induction de rémission</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Troubles de la croissance</term>
<term>Turquie</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Turquie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Systemic juvenile idiopathic arthritis (sJIA) is a distinctive subtype of JIA characterized by systemic features and poor outcome. We aimed to investigate demographic and clinical features, long-term treatment response and disease complications in a large sJIA cohort.</div>
</front>
</TEI>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><country name="Turquie"><noRegion><name sortKey="Barut, Kenan" sort="Barut, Kenan" uniqKey="Barut K" first="Kenan" last="Barut">Kenan Barut</name>
</noRegion>
<name sortKey="Adrovic, Amra" sort="Adrovic, Amra" uniqKey="Adrovic A" first="Amra" last="Adrovic">Amra Adrovic</name>
<name sortKey="Kasapcopur, Ozgur" sort="Kasapcopur, Ozgur" uniqKey="Kasapcopur O" first="Ozgur" last="Kasapcopur">Ozgur Kasapcopur</name>
<name sortKey="Koker, Oya" sort="Koker, Oya" uniqKey="Koker O" first="Oya" last="Koker">Oya Koker</name>
<name sortKey="Sahin, Sezgin" sort="Sahin, Sezgin" uniqKey="Sahin S" first="Sezgin" last="Sahin">Sezgin Sahin</name>
<name sortKey="Tahaoglu, Gulberk" sort="Tahaoglu, Gulberk" uniqKey="Tahaoglu G" first="Gulberk" last="Tahaoglu">Gulberk Tahaoglu</name>
<name sortKey="Tarcin, Gurkan" sort="Tarcin, Gurkan" uniqKey="Tarcin G" first="Gurkan" last="Tarcin">Gurkan Tarcin</name>
<name sortKey="Yildiz, Mehmet" sort="Yildiz, Mehmet" uniqKey="Yildiz M" first="Mehmet" last="Yildiz">Mehmet Yildiz</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000950 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000950 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= TocilizumabV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:31273940 |texte= Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31273940" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a TocilizumabV1
This area was generated with Dilib version V0.6.34. |